restarting semaglutide after a year Should You Stop and Restart GLP-1? What to Know What Happens After You Stop

See each compound page for individual data

(Thoma et al., 2003)

Am J Transplant (2009) 9(7):16208.10.1111/j.1600-6143.2009.02681.x 156 FriedrichMDiegelmannJSchauberJAuernhammerCJBrandS

- L- 300 3-4 8

The adverse reactions that occurred in at least two (6.1%) REPATHA-treated patients, and more frequently than in placebo-treated patients, included: Upper respiratory tract infection (9.1% versus 6.3%) Influenza (9.1% versus 0%) Gastroenteritis (6.1% versus 0%) Nasopharyngitis (6.1% versus 0%) In a multicenter, open-label 5-year extension study, 106 patients with HoFH, including 14 pediatric patients, received 420 mg of REPATHA subcutaneously once monthly or every 2 weeks [see Clinical Studies (14)]